📈 Are there any ETFs that provide exposure to the biotech sector with a focus on AI applications?

While there are no ETFs that directly combine biotech with AI exposure, several ETFs provide indirect exposure to AI applications within the biotech sector. Here are the options:

1. **Themes ETFs Launches China Generative AI ETF on Cboe (Ticker: DRGN)**:
- This ETF offers first-to-market, US listed exposure to companies leading the development of artificial intelligence technologies in China.
- It tracks the BITA China Generative AI Select Index (BCGAIS), which focuses on publicly traded Chinese companies that derive significant revenue from Generative AI-related activities.
- Although it doesn't directly focus on biotech, it captures AI innovation in China that could impact biotech globally.
2. **IonQ's Big Growth And Big Loss Test Quantum ETF Resilience**:
- IonQ's Q2 report highlights the quantum computing sector, which is transforming drug discovery alongside AI disruptors like Palantir and Recursion.
- Quantum computing ETFs like the Defiance Quantum ETF (QTUM) provide exposure to AI-first companies in biotech, though not exclusively biotech ETFs.
- QTUM's AI & Next-Gen Healthcare focus indicates it captures the AI wave in biotech.

To summarize, **DRGN** gives indirect exposure to AI innovation in China that could impact biotech, while **QTUM** and similar quantum ETFs provide exposure to AI-first companies transforming biotech. No ETFs yet directly combine biotech with AI exposure, but these options capture the intersection through indirect means.